Randal J. Kirk (#2053)
Every man will yield the results he deserves.
- $ 2 B
- Pharmaceuticals
- United States
- M
- 72 Years
Rest in Peace Ask Jeeves, every search comes to an end
County commissioners call on lawmakers to up funding for 911 dispatch systems
Spirit Airlines Is Going Out Of Business; Effective IMMEDIATELY
Pokémon Scalpers Selling Limited-Edition Pop-Tarts For Ridiculous Prices
Bennett says Netanyahu gov't 'boycotting' West Bank settlements amid Carrefour subsidy deal
Golf gear on sale now: Up to 65% off adidas, 45% off Puma, 15% off Mizuno, more
Families across the US can't find childcare — this map shows where it's worst
Median sales surge 61% in a Queens neighborhood that’s now the fifth priciest in NYC
Greg Brockman says his stake in OpenAI is worth nearly $30 billion
TeraWulf Announces Participation in Upcoming Investor and Industry Conferences
About Me
Randal Kirk, a former practicing attorney, is executive chairman of investment firm Third Security. Though the firm liquidated its life sciences-focused VC funds in 2020, it continues to manage Kirk's family money. In 2020, he stepped down as CEO of biotech firm Precigen, but was appointed executive chairman. He achieved his first entrepreneurial success with an injectable drug and vaccine distributor, which he eventually sold for $145 million. His investments have made waves for innovative products, like apples that never brown and a genetically modified species of salmon. Kirk sold greeting cards door-to-door when he was 9 years old, and claims he had an 85% close rate.
Achievements
Career Highlights
A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Randal J. Kirk’s rise and global influence.
Wealth Growth
Net Worth Growth Over Time
Tracking Randal J. Kirk’s net worth journey over the years, highlighting key growth phases and financial milestones.
Current Net Worth: $2.0B
(May 4, 2026)
© Iconic Billionaires